IMMUCOR INC
4, 1996-05-31
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: F&M BANCORP, S-4, 1996-05-31
Next: FIRST TRUST OF INSURED MUNICIPAL BONDS MULTI STATE SERIES 1, 485BPOS, 1996-05-31



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                     FORM 4

                Statement of Changes in Beneficial Ownership

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, 
Section 17(a) of the Public Utility Holding Company Act of 1935 or 
Section 30(f) of the Investment Company Act of 1940

____	Check this box if no longer subject to Section 16.  Form 4 or Form 5 
obligations may continue.  See Instruction 1(b).


1.	Name and Address of Reporting Person

	Gallup, Edward L.
	3130 Gateway Drive
	PO Box 5625
	Norcross, GA   30091-5625

2.	Issuer Name and Ticker or Trading Symbol

	Immucor, Inc./BLUD

3.	IRS or Social Security Number of Reporting Person (Voluntary)

	###-##-####

4.	Statement for Month/Year

	5/96

5.	If Amendment, Date of Original (Month/Year)

	NA

6.	Relationship of Reporting Person to Issuer (check all applicable)

	X	Director
	X	Officer (give title below)
 		10% Owner
	 	Other (specify below)

		President

TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.	Title of Security (Instr. 3)

	Common Stock, $.10 par value

2.	Transaction Date (Month/Day/Year)
	
5/29/96

3.	Transaction Code (Instr. 8)

         	Code		    V

           P       NA

4.	Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

          Amount         	(A) or (D)	             Price

          15,000             		A	              $11.25/sh

5.	Amount of Securities 	    6.	Ownership Form:	         7.	Nature of Indirect
	Beneficially Owned at 		    Direct (D) or Indirect (I)		Beneficial Ownership
	End of Month (Instr. 3		    (Instr. 4)		                (Instr. 4)
	and 4)

	        113,093	                       D	

            	514	                       I	                      by wife

Total	   113,607		


TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned 
(e.g., puts, calls, warrants, options, convertible securities)

1.	Title of Derivative Security (Instr. 3)

	NA

2.	Conversion or Exercise Price of Derivative Security

	NA

3.	Transaction Date (Month/Day/Year)

	NA

4.	Transaction Code (Instr. 8)

	     Code	    	V

      	NA	     	NA

5.	Number of Derivative Securities Acquired (A) or Disposed of (D) 
(Instr. 3, 4 and 5)

        	(A)	     	(D)

         	NA		      NA


6.	Date Exercisable and Expiration Date (Month/Day/Year)

	Date Exercisable		   Expiration Date
      		NA	             			NA

7.	Title and Amount of Underlying Securities (Instr. 3 and 4)

	Title		     Amount or Number of Shares
  NA     				         NA

8.	Price of Derivative Security (Instr. 5)

	NA

9.	Number of Derivative Securities Beneficially Owned at End of Month 
(Instr. 4)

	Other options previously reported = 149,250

10.	Ownership Form of Derivative Security:  Direct (D) or Indirect (I) 
(Instr. 4)

	D

11.	Nature of Indirect Beneficial Ownership (Instr. 4)

	NA

Explanation of Responses:

	NA



/s/ EDWARD L. GALLUP
Signature of Reporting Person

5/30/96
Date




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission